Panagora Asset Management Inc Alector, Inc. Transaction History

Panagora Asset Management Inc

$20.5 Billion
Q3 2024

A detailed history of Panagora Asset Management Inc transactions in Alector, Inc. stock. As of the latest transaction made, Panagora Asset Management Inc holds 382,409 shares of ALEC stock, worth $711,280. This represents 0.01% of its overall portfolio holdings.

Number of Shares

382,409

Previous 355,318 7.62%

Holding current value

$711,280

Previous $1.61 Million 10.66%

% of portfolio

0.01%

Previous 0.01%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$4.34 - $6.58 $117,574 - $178,258	27,091 Added 7.62%	382,409 $1.79 Million
Q2 2024 Jul 29, 2024	BUY	$4.19 - $6.23 $568,222 - $844,875	135,614 Added 61.73%	355,318 $1.61 Million
Q1 2024 May 07, 2024	SELL	$5.69 - $8.08 $96,394 - $136,883	-16,941 Reduced 7.16%	219,704 $1.32 Million
Q4 2023 Feb 08, 2024	SELL	$3.77 - $8.39 $214,471 - $477,298	-56,889 Reduced 19.38%	236,645 $1.89 Million
Q3 2023 Oct 31, 2023	BUY	$5.2 - $8.77 $267,488 - $451,128	51,440 Added 21.25%	293,534 $1.9 Million
Q2 2023 Aug 11, 2023	SELL	$5.86 - $7.93 $328,886 - $445,063	-56,124 Reduced 18.82%	242,094 $1.45 Million
Q1 2023 May 11, 2023	BUY	$5.85 - $9.84 $656,410 - $1.1 Million	112,207 Added 60.32%	298,218 $1.85 Million
Q4 2022 Feb 13, 2023	BUY	$6.88 - $9.55 $68,958 - $95,719	10,023 Added 5.7%	186,011 $1.72 Million
Q3 2022 Nov 14, 2022	BUY	$8.19 - $13.2 $908,582 - $1.46 Million	110,938 Added 170.54%	175,988 $1.67 Million
Q2 2022 Aug 15, 2022	BUY	$7.65 - $14.24 $273,594 - $509,279	35,764 Added 122.12%	65,050 $661,000
Q1 2022 May 12, 2022	BUY	$13.02 - $20.78 $190,078 - $303,367	14,599 Added 99.4%	29,286 $417,000
Q4 2021 Feb 10, 2022	BUY	$19.35 - $25.54 $284,193 - $375,105	14,687 New	14,687 $303,000

Others Institutions Holding ALEC

# of Institutions

168

Shares Held

57.8M

Call Options Held

146K

Put Options Held

90.8K

View Full List

About Alector, Inc.

Ticker ALEC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 82,563,904
Market Cap $154M
Description
Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis dise...

More about ALEC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Panagora Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Panagora Asset Management Inc with notifications on news.

Account

Panagora Asset Management Inc Alector, Inc. Transaction History